Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maneesh Jain

Showing results (41-50 of 152) with videos related to

Pageof 16
Sort By:
Expert Opinion on Therapeutic Targets|January 14, 2012
Targeting the EGFR signaling pathway in cancer therapyParthasarathy Seshacharyulu, Moorthy P Ponnusamy, Dhanya Haridas, et al.
Cancer Research|September 6, 2005
Penetratin improves tumor retention of single-chain antibodies: a novel step toward optimization of radioimmunotherapy of solid tumorsManeesh Jain, Subhash C Chauhan, Ajay P Singh, et al.
Carcinogenesis|November 14, 2016
Genetic variants of mucins: unexplored conundrumSushil Kumar, Eric Cruz, Suhasini Joshi, et al.
Cancer Treatment Reviews|January 28, 2015
Emerging potential of natural products for targeting mucins for therapy against inflammation and cancerMuzafar A Macha, Shiv Ram Krishn, Rahat Jahan, et al.
Biochimica Et Biophysica Acta|August 31, 2015
Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targetsSeema Chugh, Vinayaga S Gnanapragassam, Maneesh Jain, et al.
Nuclear Medicine and Biology|February 22, 2005
The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructsUwe A Wittel, Maneesh Jain, Apollina Goel, et al.
Cancer Metastasis Reviews|January 31, 2015
Genetically engineered mucin mouse models for inflammation and cancerSuhasini Joshi, Sushil Kumar, Sangeeta Bafna, et al.
Journal of Pharmacy & Bioallied Sciences|January 12, 2026
Human Exposure to Airborne Microplastics: A Study on Detection and Potential Health Effects Using BAL FluidMohita Pandey, Ashish Kumar Dubey, Jitendra Singh Dangi, et al.
Current Pharmaceutical Design|February 1, 2014
MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancersMuzafar A Macha, Parthasarathy Seshacharyulu, Shiv Ram Krishn, et al.
Seminars in Cancer Biology|August 30, 2022
Immune checkpoint blockade in pancreatic cancer: Trudging through the immune desertXiaoqi Li, Mansi Gulati, Alaina C Larson, et al.
Pageof 16

Showing results (41-50 of 152) with videos related to

Sort By:
Pageof 16
Expert Opinion on Therapeutic Targets|January 14, 2012
Targeting the EGFR signaling pathway in cancer therapyParthasarathy Seshacharyulu, Moorthy P Ponnusamy, Dhanya Haridas, et al.
Cancer Research|September 6, 2005
Penetratin improves tumor retention of single-chain antibodies: a novel step toward optimization of radioimmunotherapy of solid tumorsManeesh Jain, Subhash C Chauhan, Ajay P Singh, et al.
Carcinogenesis|November 14, 2016
Genetic variants of mucins: unexplored conundrumSushil Kumar, Eric Cruz, Suhasini Joshi, et al.
Cancer Treatment Reviews|January 28, 2015
Emerging potential of natural products for targeting mucins for therapy against inflammation and cancerMuzafar A Macha, Shiv Ram Krishn, Rahat Jahan, et al.
Biochimica Et Biophysica Acta|August 31, 2015
Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targetsSeema Chugh, Vinayaga S Gnanapragassam, Maneesh Jain, et al.
Nuclear Medicine and Biology|February 22, 2005
The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructsUwe A Wittel, Maneesh Jain, Apollina Goel, et al.
Cancer Metastasis Reviews|January 31, 2015
Genetically engineered mucin mouse models for inflammation and cancerSuhasini Joshi, Sushil Kumar, Sangeeta Bafna, et al.
Journal of Pharmacy & Bioallied Sciences|January 12, 2026
Human Exposure to Airborne Microplastics: A Study on Detection and Potential Health Effects Using BAL FluidMohita Pandey, Ashish Kumar Dubey, Jitendra Singh Dangi, et al.
Current Pharmaceutical Design|February 1, 2014
MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancersMuzafar A Macha, Parthasarathy Seshacharyulu, Shiv Ram Krishn, et al.
Seminars in Cancer Biology|August 30, 2022
Immune checkpoint blockade in pancreatic cancer: Trudging through the immune desertXiaoqi Li, Mansi Gulati, Alaina C Larson, et al.
Pageof 16